Saturday, April 19, 2014
Text Size

Online Product Assistant


VIVAN Life Sciences on :
Joomla Templates and Joomla Extensions by JoomlaVision.Com
About Us

About Us

VIVAN Life Sciences is Knowledge driven innovative enterprise, offering higher end level products in Pharmaceuticals and Life Sciences. We provide break through collaboration for the niche pharmaceutical products, which enhance the capability and productivity performances of our customers and Business Associates, in functions critical to their success.

Business Units

Business Units

We offer our products through the below mentioned Strategic Business Units (SBUs). These Business Units operates independently, with internal co-ordination and promotional alignment: Pharmaceutical Manufacturing Unit (PMU) Specialized Synthesis Unit (SSU)



We offer higher-end products in Pharmaceuticals and Life Sciences Companies, CROs (Contract Research Companies), Clinical Research Companies, and Speciality Chemical Companies. We have provided the higher-end products to our clientele around the world, and played an important role in the success of their Crucial projects.

Careers @ VIVAN

Careers @ VIVAN

We stand for the leadership position of excellence, in delivering quality high-end products in the field of Pharmaceuticals and Life Sciences. VIVAN aims to be a Global player in improving quality of human life.We stand to lead our Business operations, through innovation, creativity and progressiveness with methods, technologies and operating practices.

Leadership In Making

Leadership In Making

At VIVAN we believe in making of Honest, futuristic, competent, inspiring, intelligent leader. Leadership is not necessarily an inborn trait, which can be developed with proper nurturing. We mould every individual at VIVAN to give their best possible for betterment of organization, individual and society.

Corporate Social Responsibility

Corporate Social Responsibility

VIVAN is firm in its commitment to social responsibility and considers Human and Social Development as an integral part of our working process, aiming to make a difference in people’s lives. We deliver it with unstilted support from each individual in the Organization, which is a motivational factor at higher end of Human needs for each individual, that they are part of an effort which is intended to make positive difference in the lives of under privileged.

Next 1 2 3 4 5 6 Next


Sitagliptin D4 HClSitagliptin D4 HCl
Sitagliptin D4 HCl
Category: Deuterium Labeled compund
CAS No.:
Formula:C16H11F6N5OD4 . HCl
Request Quote

Captcha plugin for Joomla from Outsource Online  

  << Back   

Sitagliptin is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class.

Sitagliptin developed, and is marketed, by Merck & Co.

Sitagliptin is enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2.

Sitagliptin was approved by the U.S. Food and Drug Administration (FDA) on October 17, 2006,and is marketed in the US as Januvia by Merck & Co. On April 2, 2007

The benefit of this Sitagliptin is its fewer side effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values

CoA, MASS, NMR and HPLC will be provided along with the compounds.
All the supplied compounds are only for testing purpose, not for human consumption.

Client's Login


Industry News

New drug to combat measles developed>

WASHINGTON: Scientists have developed a novel antiviral drug that may protect people infected with the measles from getting sick and also prevent them from spreading the virus to others. . .............. 

How to Recycle Paper

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. 

Sanofi, Regeneron announce positive Phase 2a study results of asthma drug

Recycling saves the environment, but there’s more to it than just putting your recyclables on the curb.... 

Glaxo in Potential $240M Antibiotic Development Deal With U.S.

GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics...... 

New Asthma Drug Generates Excitement For Patients -- And Its Maker

An experimental asthma drug could give new hope to patients for whom existing medicines are not enough and give yet another boost to Regeneron Pharmaceuticals... 

Compulsory licence likely for three cancer drugs

The government has appointed a panel to look into issues related to compulsory licensing of drugs and whether cheaper versions of cancer medicines Trastuzumab, Ixabepilone and Dasatinib can be launched under the provision... 

The Top 10 Pinnacle Moments in the Pharma Industry

The development of vaccines, antibiotics and prescription drugs and the emergence of the pharmaceutical industry has undoubtedly saved millions of lives, protecting against, and even eliminating, viruses and diseases that were once among the leading causes of death. 

Australia & India to start joint research in field of vaccines, immunotherapeutics & immunomodulators

MUMBAI: Under the guidelines established by Indo-Australian Biotechnology Fund (IABF), the Department of Biotechnology (DBT) and the Department of Industry, Innovation, Science, Research and Tertiary Education of the Australian government (DIISRTE) are soon going to begin the process of joint research in the important area of vaccines, biotechnological interventions,immunomodulators and immunotherapeutics for enhanced productivity in agriculture for the advantage of the SME industry in India. 

Current Openings

1. Role: Associate/ Sr. Associate - Business Development, Location : Mumbai, Qualifications :B Sc (Chem.) / B Pharm with MBA, Apply At  

2. Role: Project Coordinator, Location : Mumbai, Qualifications :B Sc (Chem.) / B Pharma, Apply At  


About Us
Culture & Values
Why Vivan
R & D Center
Vivan's CSR
How we work
Reach Us


  Vivan's CSR

  Contact Us

VIVAN Life Sciences Pvt. Limited.
502, Rutu Business Park,
Besides Eastern Express Highway,
Off LBS Marg, Service Road,
Thane-W, Mumbai - 400 601,

Ph. : +91(22) 2544 4584 / 85 / 86/86 / 87
Fax : +91(22) 2544 4588